CR20110078A - PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES - Google Patents

PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES

Info

Publication number
CR20110078A
CR20110078A CR20110078A CR20110078A CR20110078A CR 20110078 A CR20110078 A CR 20110078A CR 20110078 A CR20110078 A CR 20110078A CR 20110078 A CR20110078 A CR 20110078A CR 20110078 A CR20110078 A CR 20110078A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutical compositions
somatotrophic
hormones
somatotrophic hormones
composition
Prior art date
Application number
CR20110078A
Other languages
Spanish (es)
Inventor
Andrew Naylor
Andrew Lester Lewis
Lisbeth Illum
Original Assignee
Critical Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39722152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20110078(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Critical Pharmaceuticals Ltd filed Critical Critical Pharmaceuticals Ltd
Publication of CR20110078A publication Critical patent/CR20110078A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende una hormona somatotrófica; un componente polimérico biodegradable; y un modificador de liberación. Tambien se proporciona un proceso para preparar y usar tal composición.The present invention relates to a composition comprising a somatotrophic hormone; a biodegradable polymer component; and a release modifier. A process for preparing and using such a composition is also provided.

CR20110078A 2008-07-11 2011-02-11 PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES CR20110078A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812740.9A GB0812740D0 (en) 2008-07-11 2008-07-11 Composition

Publications (1)

Publication Number Publication Date
CR20110078A true CR20110078A (en) 2011-05-03

Family

ID=39722152

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110078A CR20110078A (en) 2008-07-11 2011-02-11 PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES

Country Status (18)

Country Link
US (1) US20110257097A1 (en)
EP (1) EP2317979A2 (en)
JP (1) JP2011527329A (en)
KR (1) KR20110040892A (en)
CN (1) CN102131498A (en)
AU (1) AU2009269818A1 (en)
BR (1) BRPI0915857A2 (en)
CA (1) CA2730325A1 (en)
CL (1) CL2011000063A1 (en)
CO (1) CO6331422A2 (en)
CR (1) CR20110078A (en)
EA (1) EA201170180A1 (en)
GB (2) GB0812740D0 (en)
IL (1) IL210555A0 (en)
MA (1) MA32545B1 (en)
MX (1) MX2011000259A (en)
WO (1) WO2010004299A2 (en)
ZA (1) ZA201101053B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0812742D0 (en) 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
EP2165919A1 (en) 2008-09-19 2010-03-24 Sika Technology AG Reinforced structure for vehicles
CN101972212A (en) * 2010-10-29 2011-02-16 华侨大学 Method for preparing core-shell type composite microspheres by supercritical fluid technology
KR20160038801A (en) * 2014-09-29 2016-04-07 (주)엘지하우시스 Polymer powder and the preparing method for the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100210509B1 (en) * 1996-01-10 1999-07-15 성재갑 Composition for sustained release of animal growth hormone and method for preparation thereof
US6444223B1 (en) * 1999-05-28 2002-09-03 Alkermes Controlled Therapeutics, Inc. Method of producing submicron particles of a labile agent and use thereof
KR20010002589A (en) * 1999-06-16 2001-01-15 김윤 Process for preparing biodegradable microspheres containing physiologically active agents
KR100622996B1 (en) * 2005-03-03 2006-09-14 한국과학기술원 Nonporous microspheres including drug and manufacturing method thereof
PL2079767T3 (en) * 2006-10-11 2015-05-29 Tolmar Therapeutics Inc Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction

Also Published As

Publication number Publication date
EA201170180A1 (en) 2011-08-30
CA2730325A1 (en) 2010-01-14
WO2010004299A2 (en) 2010-01-14
KR20110040892A (en) 2011-04-20
WO2010004299A3 (en) 2010-11-11
MA32545B1 (en) 2011-08-01
BRPI0915857A2 (en) 2015-11-03
CN102131498A (en) 2011-07-20
AU2009269818A1 (en) 2010-01-14
MX2011000259A (en) 2011-04-05
GB201102015D0 (en) 2011-03-23
JP2011527329A (en) 2011-10-27
CO6331422A2 (en) 2011-10-20
CL2011000063A1 (en) 2011-09-23
ZA201101053B (en) 2012-07-25
US20110257097A1 (en) 2011-10-20
IL210555A0 (en) 2011-03-31
GB0812740D0 (en) 2008-08-20
EP2317979A2 (en) 2011-05-11
GB2474001A (en) 2011-03-30

Similar Documents

Publication Publication Date Title
UY31863A (en) DRUG COMBINATIONS UNDERSTANDING A DGAT INHIBITOR AND A PPAR AGONIST
EA201001555A1 (en) ANTIOXIDATIVE INFLAMMATION MODULATORS: DERIVATIVESIC DERIVATIVES WITH AMINUM AND OTHER MODIFICATIONS OF C-17
JO3172B1 (en) Synthetic bile acid composition,method,and preparation
BRPI0717570B8 (en) solid pharmaceutical composition suitable for oral administration, its use and its production process
ECSP088800A (en) DPP IV inhibitor formulations
ES2556585T3 (en) Compositions comprising salbutamol sulfate
AR060030A1 (en) DIESTERS OF RAMBED CARBOXYLIC ACIDS
CR20110078A (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOTROPHIC HORMONES
AR059742A1 (en) PHARMACEUTICAL FORMULATIONS OF AN ANHYDRA CRYSTAL FORM OF 2- (3- FLUOR-4- DIHYDROXIFENIL) 7- VINIL-1,3- BENZOXAZOL -5-OL
MY155611A (en) Curing agent composition
MX2011007267A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
ECSP12012155A (en) HYDROCHLORIDE HYDROCHLORIDE HYDROCHLORIDE AND
CU20090200A7 (en) A COMPOSITION OF PROLONGED RELEASE THAT INCLUDES A SOMATOSTATIN DERIVATIVE IN MICROPARTS
MX2011007451A (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives.
BR112012015194A2 (en) cosmetic compositions of powder microspheres
CL2007002844A1 (en) COMPOSITION OF FILLED ELASTOMEROS WHICH IT INCLUDES RUBBER COMPONENT, PARTICULATED FILLING AND MERCAPTOFUNCTIONAL SILANO; PRODUCT; PROCESS TO MANUFACTURE COMPOSITION OF ELASTOMEROS FILLENOS; AND PROCESS TO MAKE RUBBER COMPOSITION.
BR112013024982A2 (en) collage compositions
BR112013027619A2 (en) curing process for concrete
BRPI1015042A2 (en) acid-labile triggering units
BR112017028185A2 (en) solid pharmaceutical compositions for treating hcv
CL2008003711A1 (en) Process for preparing a pharmaceutical dosage form comprising florfenicol or an analog thereof; and to recover florfenicol or an analog of a pharmaceutical composition.
BR112018000982A2 (en) solid pharmaceutical compositions for treating hcv
UY32360A (en) ETHANAMINE COMPOUNDS AND METHODS OF USE OF THE SAME 545
DOP2015000127A (en) PHARMACEUTICAL FORMULATION OF N- [5- [2- (3,5-DIMETOXIFENIL) ETIL] -2H-PIRAZOL-3-IL] -4 - [(3R, 5S) -3,5-DIMETHYLIPIPERAZIN-1-IL] BENZAMIDA
TN2010000615A1 (en) Pharmaceutical compositions of somatotrophic hormones